<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2024-17-3-7-12</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-1542</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СТАТЬЯ НОМЕРА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LEADING ARTICLE</subject></subj-group></article-categories><title-group><article-title>Эпидемиология глаукомы в Российской Федерации</article-title><trans-title-group xml:lang="en"><trans-title>Glaucoma epidemiology in the Russian Federation</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8480-0894</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нероев</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Neroev</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нероев Владимир Владимирович — академик РАН, д-р мед. наук, профессор, директор ФГБУ «НМИЦ глазных болезней им. Гельмгольца» Минздрава России; заведующий кафедрой глазных болезней факультета дополнительного профессионального образования ФГБОУ ВО «МГМСУ им. А.И. Евдокимова» Минздрава России.</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062; ул. Делегатская, д. 20, стр. 1, Москва, 127473</p></bio><bio xml:lang="en"><p>Vladimir V. Neroev — Academician of RAS, Dr. of Med. Sci., professor, director, Helmholtz National Medical Research Center of Eye Diseases; head of chair of eye diseases of the faculty of additional professional education, A.I. Evdokimov Moscow State University of Medicine and Dentistry.</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062; 20, Bldg.1, Delegatskaya St., Moscow, 127473</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0523-9734</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Михайлова</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikhaylova</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Михайлова Людмила Анатольевна — помощник директора по лечебной и организационной работе, государственный советник Российской Федерации 3-го класса.</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Ludmila A. Mikhaylova — Director assistant in clinical and organizing activity, 3rd degree state advisor.</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3679-8619</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малишевская</surname><given-names>Т. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Malishevskaya</surname><given-names>T. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Малишевская Татьяна Николаевна — д-р мед. наук, заведующая отделением аналитической работы.</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Tatiana N. Malishevskaya — Dr. of Med. Sci., head of the department of analytics.</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6922-0464</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петров</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrov</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Петров Сергей Юрьевич — д-р мед. наук, начальник отдела глаукомы.</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Sergey Yu. Petrov — Dr. of Med. Sci., head of the glaucoma department.</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><email xlink:type="simple">glaucomatosis@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9082-4537</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Филиппова</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Filippova</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Филиппова Ольга Маратовна — канд. мед. наук, научный сотрудник отдела глаукомы.</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Olga M. Filippova – Cand. of Med. Sci., researcher, glaucoma department.</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ глазных болезней им. Гельмгольца» Минздрава России; ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Helmholtz National Medical Research Center of Eye Diseases; A.I. Evdokimov Moscow State University of Medicine and Dentistry</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ глазных болезней им. Гельмгольца» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Helmholtz National Medical Research Center of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>01</day><month>10</month><year>2024</year></pub-date><volume>17</volume><issue>3</issue><fpage>7</fpage><lpage>12</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Нероев В.В., Михайлова Л.А., Малишевская Т.Н., Петров С.Ю., Филиппова О.М., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Нероев В.В., Михайлова Л.А., Малишевская Т.Н., Петров С.Ю., Филиппова О.М.</copyright-holder><copyright-holder xml:lang="en">Neroev V.V., Mikhaylova L.A., Malishevskaya T.N., Petrov S.Y., Filippova O.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/1542">https://roj.igb.ru/jour/article/view/1542</self-uri><abstract><p>Глаукома является наиболее частой причиной необратимой слепоты во всем мире. Ее распространенность в возрастной группе старше 40 лет составляет в среднем около 3,5 % и коррелирует с возрастом. Наиболее распространенной является первичная открытоугольная глаукома (ПОУГ). Прогнозируемое увеличение распространенности ПОУГ в мире оценивается с 76,0 млн, по данным на 2020 г., до 111,8 млн к 2040 г. В Российской Федерации (РФ) в 2022 г. зарегистрировано 1 250 558 больных глаукомой, из них пациентов с впервые выявленной глаукомой — 110 680 человек. Общая заболеваемость глаукомой в РФ характеризуется устойчивой тенденцией к росту: в 2022 г. она увеличилась на 30 % по сравнению с 2013 г. Показатели организации медицинской помощи населению с глаукомной патологией в России имеют положительную динамику: охват диспансерным наблюдением пациентов вырос за 10 лет на 6,8 %, частота хирургического лечения увеличилась на 28,1 %.</p></abstract><trans-abstract xml:lang="en"><p>Glaucoma is worldwide the most common cause of irreversible blindness. Its prevalence in the population older than 40 years is about 3.5 %, and correlates with age. The most common type is primary open-angle glaucoma (POAG). The global prevalence of POAG is expected to grow from 76.0 million in 2020 to 111.8 million by 2040. In 2022, a total of 1,250,558 patients with glaucoma were registered in the Russian Federation, of which 110,680 had newly diagnosed glaucoma. The overall glaucoma incidence rate in Russia shows a steady growth: in 2022, it increased by 30 % as compared to 2013. In order to meet the challenge, medical care of glaucomatous patients is on the rise: the contingent receiving dispensary observation increased by 6.8 % over the last 10 years,  whilst surgical treatment involved 28.1 % more patients.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>глаукома</kwd><kwd>эпидемиология</kwd><kwd>инвалидность</kwd><kwd>диагностика</kwd><kwd>мониторинг</kwd><kwd>клинические рекомендации</kwd></kwd-group><kwd-group xml:lang="en"><kwd>glaucoma</kwd><kwd>epidemiology</kwd><kwd>disability</kwd><kwd>diagnostics</kwd><kwd>monitoring</kwd><kwd>clinical guidelines</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">European Glaucoma Society. Terminology and guidelines for glaucoma. 5th edition: Savona, Italy PubliComm; 2020.</mixed-citation><mixed-citation xml:lang="en">European Glaucoma Society. Terminology and guidelines for glaucoma. 5th edition: Savona, Italy PubliComm; 2020.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации «Глаукома первичная открытоугольная» 2020 (16.02.2021), утверждены Минздравом РФ.</mixed-citation><mixed-citation xml:lang="en">Clinical Gidelines “Primary open angle glaucoma”. 2020 (16.02.2021), approved by the Ministry of Health of the Russian Federation (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Нестеров А.П. Глаукома. Москва: Медицина; 1995.</mixed-citation><mixed-citation xml:lang="en">Nesterov A.P. Glaucoma. Moscow: Medicine; 1995 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90 (3): 262–7. doi:10.1136/bjo.2005.081224</mixed-citation><mixed-citation xml:lang="en">Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90 (3): 262–7. doi:10.1136/bjo.2005.081224</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Нероев В.В. Офтальмологическая заболеваемость в России. В кн.: Аветисов С.Э., Егоров Е.А., Мошетова Л.К., Тахчиди Х.П., ред. «Офтальмология. Национальное руководство». Москва: ГЭОТАР-Медиа. 2018: 15–9.</mixed-citation><mixed-citation xml:lang="en">Neroev V.V. Ophthalmological morbidity in Russia. In: Avetisov S.E., Egorov E.A., Moshetova L.K., Takhchidi Kh.P., eds. Ophthalmology. National Guide. Moscow: GEOTAR-Media; 2018: 15–9 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Jonas JB, Aung T, Bourne RR, et al. Glaucoma. Lancet. 2017; 390 (10108): 2183–93. doi:10.1016/S0140-6736(17)31469-1</mixed-citation><mixed-citation xml:lang="en">Jonas JB, Aung T, Bourne RR, et al. Glaucoma. Lancet. 2017; 390 (10108): 2183–93. doi:10.1016/S0140-6736(17)31469-1</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">World report on vision. World Health Organization. 2019 [29.02.2024]. Available at: https://cdn.who.int/media/docs/default-source/blindness-and-visual-impairment/9789241516570-eng.pdf?sfvrsn=dd15adbb_3</mixed-citation><mixed-citation xml:lang="en">World report on vision. World Health Organization. 2019 [29.02.2024]. Available at: https://cdn.who.int/media/docs/default-source/blindness-and-visual-impairment/9789241516570-eng.pdf?sfvrsn=dd15adbb_3</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121 (11): 2081–90. doi:10.1016/j.ophtha.2014.05.013</mixed-citation><mixed-citation xml:lang="en">Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121 (11): 2081–90. doi:10.1016/j.ophtha.2014.05.013</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Chou R, Selph S, Blazina I, et al. Screening for glaucoma in adults: Updated evidence report and systematic review for the US preventive services task force. JAMA. 2022; 327 (20): 1998–2012. doi:10.1001/jama.2022.6290</mixed-citation><mixed-citation xml:lang="en">Chou R, Selph S, Blazina I, et al. Screening for glaucoma in adults: Updated evidence report and systematic review for the US preventive services task force. JAMA. 2022; 327 (20): 1998–2012. doi:10.1001/jama.2022.6290</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Нероев В.В., Киселева О.А., Бессмертный А.М. Основные результаты мультицентрового исследования эпидемиологических особенностей первичной открытоугольной глаукомы в Российской Федерации. Российский офтальмологический журнал. 2013; 6 (3): 4–7.</mixed-citation><mixed-citation xml:lang="en">Neroev V.V., Kiseleva O.A., Bessmertny A.M. Main results of a multicenter study of the epidemiological features of primary open-angle glaucoma in the Russian Federation. Russian ophthalmological journal. 2013; 6 (3): 4–7 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Friedman DS, Nordstrom B, Mozaffari E, Quigley HA. Glaucoma management among individuals enrolled in a single comprehensive insurance plan. Ophthalmology. 2005; 112 (9): 1500–04. doi:10.1016/j.ophtha.2005.02.030</mixed-citation><mixed-citation xml:lang="en">Friedman DS, Nordstrom B, Mozaffari E, Quigley HA. Glaucoma management among individuals enrolled in a single comprehensive insurance plan. Ophthalmology. 2005; 112 (9): 1500–04. doi:10.1016/j.ophtha.2005.02.030</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Li T, Lindsley K, Rouse B, et al. Comparative effectiveness of first-line medications for primary open-angle glaucoma: A systematic review and network meta-analysis. Ophthalmology. 2016; 123 (1): 129–40. doi:10.1016/j.ophtha.2015.09.005</mixed-citation><mixed-citation xml:lang="en">Li T, Lindsley K, Rouse B, et al. Comparative effectiveness of first-line medications for primary open-angle glaucoma: A systematic review and network meta-analysis. Ophthalmology. 2016; 123 (1): 129–40. doi:10.1016/j.ophtha.2015.09.005</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Musch DC, Lichter PR, Guire KE, Standardi CL. The collaborative initial glaucoma treatment study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999; 106 (4): 653–62. doi:10.1016/s0161-6420(99)90147-1</mixed-citation><mixed-citation xml:lang="en">Musch DC, Lichter PR, Guire KE, Standardi CL. The collaborative initial glaucoma treatment study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999; 106 (4): 653–62. doi:10.1016/s0161-6420(99)90147-1</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Заболеваемость всего населения России в 2022 г.: Министерство здравоохранения Российской Федерации, ФГБУ «Центральный научно-исследовательский институт организации и информатизации здравоохранения»; 2022.</mixed-citation><mixed-citation xml:lang="en">Morbidity rate of the entire population of Russia in 2022: Ministry of Health of the Russian Federation Federal State Budgetary Institution “Central Research Institute for Organization and Informatization of Health Care”; 2022 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Общая заболеваемость всего населения России в 2022 г.: Министерство здравоохранения Российской Федерации, ФГБУ «Центральный научно-исследовательский институт организации и информатизации здравоохранения»; 2022.</mixed-citation><mixed-citation xml:lang="en">General morbidity rate of the entire population of Russia in 2022: Ministry of Health of the Russian Federation Federal State Budgetary Institution “Central Research Institute of Organization and Informatization of Health Care”; 2022 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Отчетные формы федерального статистического наблюдения № 12 «Сведения о числе заболеваний, зарегистрированных у пациентов, проживающих в районе обслуживания медицинской организации» за 2022 г.</mixed-citation><mixed-citation xml:lang="en">Federal statistical observation reporting forms No. 12 “Information on the number of diseases registered in patients living in the service area of a medical organization” for 2022 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang N, Wang J, Li Y, Jiang B. Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review. Sci Rep. 2021; 11 (1): 13762. doi:10.1038/s41598-021-92971-w</mixed-citation><mixed-citation xml:lang="en">Zhang N, Wang J, Li Y, Jiang B. Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review. Sci Rep. 2021; 11 (1): 13762. doi:10.1038/s41598-021-92971-w</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
